|
US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
|
IT1111367B
(it)
*
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
|
EP0032578B1
(de)
|
1980-01-16 |
1984-07-25 |
Hans Georg Prof. Dr. Weder |
Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
|
|
US4302459A
(en)
*
|
1980-03-19 |
1981-11-24 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
|
|
EP0043327B1
(fr)
*
|
1980-07-01 |
1984-01-18 |
L'oreal |
Procédé d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible à l'eau et dispersions correspondantes
|
|
DE3173713D1
(en)
*
|
1980-09-05 |
1986-03-20 |
Frappier Armand Inst |
Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
|
|
GR77320B
(US20030157025A1-20030821-C00031.png)
*
|
1980-12-22 |
1984-09-11 |
Procter & Gamble |
|
|
US4394372A
(en)
*
|
1980-12-22 |
1983-07-19 |
The Procter & Gamble Company |
Process for making lipid membrane structures
|
|
EP0072234B1
(en)
*
|
1981-08-10 |
1986-02-26 |
The Wellcome Foundation Limited |
Pharmaceutical formulations containing antimony
|
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
DE3374837D1
(en)
*
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
US4416872A
(en)
*
|
1982-03-17 |
1983-11-22 |
The United States Of America As Represented By The Secretary Of The Army |
Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
|
|
US4522803A
(en)
*
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
|
WO1983003383A1
(en)
*
|
1982-03-29 |
1983-10-13 |
Liposome Co Inc |
Stable plurilamellar vesicles
|
|
US5435989A
(en)
|
1982-03-30 |
1995-07-25 |
Vestar, Inc. |
Method of targeting a specific location in a body
|
|
US5441745A
(en)
*
|
1982-03-30 |
1995-08-15 |
Vestar, Inc. |
Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
|
|
US4612370A
(en)
*
|
1982-04-02 |
1986-09-16 |
The Regents Of The University Of California |
Lipid-saccharide reaction products
|
|
US4425334A
(en)
|
1982-04-02 |
1984-01-10 |
The Regents Of The University Of California |
Functional oxygen transport system
|
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
EP0100964A3
(de)
*
|
1982-07-31 |
1984-06-13 |
Reifenrath, Rainer, Dr. |
Pharmazeutisches Erzeugnis zur Behandlung und Prophylaxe von Infektionen sowie von Husten und obstruktiven Atemwegserkrankungen sowie Verfahren zu seiner Herstellung
|
|
US4485054A
(en)
*
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
|
US4501728A
(en)
*
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
FR2540381B1
(fr)
*
|
1983-02-08 |
1986-05-30 |
Dior Sa Parfums Christian |
Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
|
|
US5387410A
(en)
*
|
1983-03-18 |
1995-02-07 |
Mallinckrodt, Inc. |
Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
|
|
US4588578A
(en)
*
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
|
WO1995013796A1
(en)
*
|
1993-11-16 |
1995-05-26 |
Depotech Corporation |
Vesicles with controlled release of actives
|
|
FR2561101B1
(fr)
*
|
1984-03-13 |
1986-10-31 |
Paris Sud Universite |
Procede de preparation de liposomes et liposomes ainsi obtenus
|
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US5231112A
(en)
*
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
|
US4921706A
(en)
*
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4707453A
(en)
*
|
1985-04-05 |
1987-11-17 |
Becton Dickinson And Company |
Vesicle including a metal marker for use in an assay
|
|
US4698263A
(en)
*
|
1985-05-23 |
1987-10-06 |
Becton Dickinson And Company |
Sac having a marker linked thereto
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US4861580A
(en)
*
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
|
FR2591105B1
(fr)
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
|
JPH0751496B2
(ja)
*
|
1986-04-02 |
1995-06-05 |
武田薬品工業株式会社 |
リポソ−ムの製造法
|
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
|
US6759057B1
(en)
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
EP0269720B1
(en)
*
|
1986-06-16 |
1992-02-19 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
DE3777640D1
(US20030157025A1-20030821-C00031.png)
*
|
1986-11-28 |
1992-04-23 |
The Liposome Co.,Inc., Princeton, N.J., Us |
|
|
US4783220A
(en)
*
|
1986-12-18 |
1988-11-08 |
Xerox Corporation |
Vesicle ink compositions
|
|
DE3785198T3
(de)
*
|
1986-12-23 |
1999-09-02 |
Liposome Co Inc |
Liposomes präparat und antibiotikum.
|
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
GB8704171D0
(en)
*
|
1987-02-23 |
1987-04-01 |
Clayton Found Res |
Multivesicular liposomes
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
|
US5017501A
(en)
*
|
1987-11-25 |
1991-05-21 |
Abbott Laboratories |
Preparation of uniformly sized liposomes encapsulating an aqueous liquid
|
|
US4873035A
(en)
*
|
1987-11-25 |
1989-10-10 |
Abbott Laboratories |
Preparation of sized populations of liposomes
|
|
KR900000848B1
(ko)
*
|
1987-12-30 |
1990-02-17 |
태평양화학 주식회사 |
리포좀을 함유한 화장료의 제조방법
|
|
US5807572A
(en)
*
|
1988-02-18 |
1998-09-15 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
|
US5948441A
(en)
*
|
1988-03-07 |
1999-09-07 |
The Liposome Company, Inc. |
Method for size separation of particles
|
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
CA1339034C
(en)
*
|
1988-08-22 |
1997-04-01 |
Paul A. Tremblay |
Platinum complexes of single isomer neoalkyl acids
|
|
US5043165A
(en)
*
|
1988-12-14 |
1991-08-27 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs
|
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
|
US5116615A
(en)
*
|
1989-01-27 |
1992-05-26 |
Immunolytics, Inc. |
Method for treating benign prostatic hypertrophy
|
|
JP3054190B2
(ja)
|
1989-01-27 |
2000-06-19 |
イムノリティックス・インコーポレイテッド |
良性前立腺肥大処置のための組成物および方法
|
|
US5078986A
(en)
*
|
1989-02-15 |
1992-01-07 |
Mallinckrodt Medical, Inc. |
Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
|
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
US5221535A
(en)
*
|
1989-11-13 |
1993-06-22 |
Nova Pharmaceutical Corporation |
Sustained release formulations of insect repellent
|
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US6088613A
(en)
*
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
NZ237464A
(en)
*
|
1990-03-21 |
1995-02-24 |
Depotech Corp |
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
IN172208B
(US20030157025A1-20030821-C00031.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
JP3533215B2
(ja)
*
|
1990-07-31 |
2004-05-31 |
ザ リポソーム カンパニー，インコーポレイテッド |
アミノ酸及びペプチドのリポソーム内への蓄積
|
|
DE69120543T2
(de)
*
|
1990-09-06 |
1997-01-09 |
Johnson & Son Inc S C |
Verfahren zur stabilisierung von liposomen sowie diese enthaltende mittel
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
|
US5567432A
(en)
*
|
1991-08-02 |
1996-10-22 |
Lau; John R. |
Masking of liposomes from RES recognition
|
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
US5455044A
(en)
*
|
1993-05-14 |
1995-10-03 |
Depotech Corporation |
Method for treating neurological disorders
|
|
EP1118326A3
(en)
*
|
1993-05-21 |
2002-07-31 |
The Liposome Company, Inc. |
Reduction of liposome-induced adverse physiological reactions
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
NZ276167A
(en)
|
1993-12-15 |
1996-11-26 |
Bracco Research Sa |
Ultrasound contrast medium comprising two gases in aqueous suspension
|
|
EP0748215B1
(en)
*
|
1994-02-17 |
2003-05-28 |
New York Blood Center, Inc. |
Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
|
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
|
US6455304B1
(en)
*
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
|
US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US5800833A
(en)
*
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
|
US5824638A
(en)
*
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
|
JPH11510795A
(ja)
*
|
1995-07-14 |
1999-09-21 |
グリコテック コーポレイション |
Ｅｇｆレセプターに関連する癌の処置のための化合物および方法、ならびにｅｇｆレセプターの精製
|
|
US6022500A
(en)
*
|
1995-09-27 |
2000-02-08 |
The United States Of America As Represented By The Secretary Of The Army |
Polymer encapsulation and polymer microsphere composites
|
|
US6447800B2
(en)
|
1996-01-18 |
2002-09-10 |
The University Of British Columbia |
Method of loading preformed liposomes using ethanol
|
|
US6143287A
(en)
*
|
1996-02-27 |
2000-11-07 |
New York Blood Center, Inc. |
Method and composition for hair removal
|
|
DE69736981D1
(de)
|
1996-05-01 |
2007-01-04 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
ATE231004T1
(de)
*
|
1996-09-11 |
2003-02-15 |
Imarx Pharmaceutical Corp |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
|
US5997899A
(en)
*
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
DE69841002D1
(de)
*
|
1997-05-14 |
2009-09-03 |
Univ British Columbia |
Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
|
|
EP2113247A3
(en)
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
|
US6123956A
(en)
*
|
1997-07-10 |
2000-09-26 |
Keith Baker |
Methods for universally distributing therapeutic agents to the brain
|
|
US6306432B1
(en)
|
1997-09-08 |
2001-10-23 |
Chiron Corporation |
High and low load formulations of IGF-I in multivesicular liposomes
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
DK1014946T3
(da)
|
1997-09-18 |
2010-06-28 |
Pacira Pharmaceuticals Inc |
Liposomale anæstetiske sammensætninger med forsinket frigivelse
|
|
CN101113436B
(zh)
*
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
|
CN1322121C
(zh)
*
|
1997-10-31 |
2007-06-20 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
|
EP1030652B1
(en)
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
US6727079B1
(en)
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
|
US6987023B2
(en)
*
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
|
US7223571B2
(en)
*
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
US20080108110A1
(en)
*
|
1998-04-02 |
2008-05-08 |
Deangelis Paul L |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
US20060188966A1
(en)
*
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
|
US7169410B1
(en)
*
|
1998-05-19 |
2007-01-30 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
|
US7094581B2
(en)
*
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
CA2401749A1
(en)
|
2000-03-23 |
2001-09-27 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
|
US20050287638A1
(en)
*
|
2000-04-25 |
2005-12-29 |
Weigel Paul H |
Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
|
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
CA2410972A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
|
PL363618A1
(en)
*
|
2000-11-09 |
2004-11-29 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
|
US20020150566A1
(en)
*
|
2001-03-23 |
2002-10-17 |
Kun-Liang Guan |
Method of inhibiting cancerous cell proliferation using Ras mutants of GDP-bound conformation
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
WO2003002122A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
|
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
|
BRPI0105509B8
(pt)
*
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
|
JP2005516897A
(ja)
*
|
2001-11-07 |
2005-06-09 |
イネックス ファーマシューティカルズ コーポレイション |
改善された粘膜のワクチン及びその使用方法
|
|
US7476400B2
(en)
*
|
2001-11-13 |
2009-01-13 |
Ferndale Ip, Inc. |
High-concentration lidocaine compositions and methods for their preparation
|
|
US20070020737A1
(en)
*
|
2001-12-03 |
2007-01-25 |
Pummill Philip E |
Hyaluronan synthases and methods of making and using same
|
|
US20030134423A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
|
AU2003205048B2
(en)
*
|
2002-01-09 |
2009-02-26 |
Transave, Inc. |
Efficient liposomal encapsulation
|
|
US20030180348A1
(en)
*
|
2002-03-22 |
2003-09-25 |
Levinson R. Saul |
Transcellular drug delivery system
|
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
PT1581236E
(pt)
|
2002-10-29 |
2013-12-24 |
Insmed Inc |
Libertação prolongada de anti-infecciosos
|
|
AU2003298738A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Su-Ming Chiang |
Liposomal formulations
|
|
US6866856B2
(en)
*
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
EP1695696A1
(en)
*
|
2003-12-01 |
2006-08-30 |
Mitsubishi Pharma Corporation |
Liposome
|
|
US7504385B2
(en)
*
|
2003-12-17 |
2009-03-17 |
Avon Products, Inc. |
si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
|
|
EP2407169A1
(en)
|
2004-04-22 |
2012-01-18 |
Celator Pharmaceuticals, Inc. |
Combination formulations of anthracycline agents and cytidine analogs
|
|
EP1786443B1
(en)
|
2004-07-19 |
2018-06-06 |
Celator Pharmaceuticals, Inc. |
Particulate constructs for release of active agents
|
|
EP1807051A2
(en)
|
2004-11-05 |
2007-07-18 |
Inex Pharmaceuticals Corporation |
Compositions and methods for stabilizing liposomal camptothecin formulations
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
|
EP1838289B1
(en)
|
2004-12-20 |
2017-12-13 |
Australian Nuclear Science And Technology Organisation |
Controlled release of biological entities
|
|
AU2005318928B2
(en)
*
|
2004-12-20 |
2010-06-03 |
Australian Nuclear Science & Technology Organisation |
Controlled release of biological entities
|
|
AU2006257727B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Encap Hive Pty Ltd |
Particles comprising a releasable dopant therein
|
|
KR101205481B1
(ko)
*
|
2005-06-17 |
2012-11-27 |
오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 |
방출 가능한 도펀트를 함유한 입자
|
|
AU2006257726B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Australian Nuclear Science And Technology Organisation |
Particles having hydrophobic material therein
|
|
MX2007016021A
(es)
*
|
2005-06-17 |
2008-04-16 |
Australian Nuclear Science Tec |
Particulas que tienen material hidrofobico en estas.
|
|
WO2007032225A1
(ja)
*
|
2005-09-15 |
2007-03-22 |
Kyoto University |
リポソーム、リポソームの製造方法及び微小反応空間内での反応制御方法
|
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9149543B2
(en)
*
|
2005-12-15 |
2015-10-06 |
The Trustees Of The University Of Pennsylvania |
Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors
|
|
US20080094573A1
(en)
*
|
2006-04-04 |
2008-04-24 |
Vermette Patrick |
Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
|
|
ATE531727T1
(de)
|
2006-09-18 |
2011-11-15 |
Compugen Ltd |
Bioaktive peptide und verfahren zu ihrer verwendung
|
|
EP2690178B1
(en)
|
2006-10-03 |
2021-12-22 |
The Board Of Regents Of The University Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
|
WO2008130641A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Biocure, Inc. |
Drug delivery vehicle containing vesicles in a hydrogel base
|
|
US8492329B2
(en)
|
2007-07-12 |
2013-07-23 |
Compugen Ltd. |
Bioactive peptides and methods of using same
|
|
ITRM20070394A1
(it)
*
|
2007-07-16 |
2009-01-17 |
Uni Cattolica Del Sacro Cuo Re |
Liposomi asimmetrici e loro usi in campo medico.
|
|
ES2550759T3
(es)
|
2007-08-17 |
2015-11-12 |
Celator Pharmaceuticals, Inc. |
Formulaciones farmacológicas de platino mejoradas
|
|
WO2009082607A2
(en)
|
2007-12-04 |
2009-07-02 |
Alnylam Pharmaceuticals, Inc. |
Targeting lipids
|
|
WO2009076323A2
(en)
|
2007-12-06 |
2009-06-18 |
Genalyte Inc. |
Monitoring enzymatic process
|
|
EP2231190B1
(en)
*
|
2007-12-06 |
2012-09-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Particulate drug carriers as desensitizing agents
|
|
US9006191B2
(en)
|
2007-12-27 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering RNA
|
|
WO2009086558A1
(en)
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
WO2009127060A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
JP2011516094A
(ja)
|
2008-04-15 |
2011-05-26 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉ｒｎａを用いたｃｓｎ５遺伝子発現のサイレンシング方法
|
|
CA2736982C
(en)
|
2008-09-11 |
2019-01-15 |
I.B.R. Israeli Biotechnology Research Ltd. |
Leucojum bulb extracts and use thereof
|
|
US9139554B2
(en)
|
2008-10-09 |
2015-09-22 |
Tekmira Pharmaceuticals Corporation |
Amino lipids and methods for the delivery of nucleic acids
|
|
EP2347247B1
(en)
|
2008-10-27 |
2019-06-26 |
Genalyte, Inc. |
Biosensors based on optical probing and sensing
|
|
EP3238738B1
(en)
|
2008-11-10 |
2020-09-23 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
|
CA2751342C
(en)
|
2009-01-29 |
2019-05-07 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulations comprising cationic lipid and a targeting lipid comprising n-acetyl galactosamine for delivery of nucleic acid
|
|
WO2010092597A2
(en)
|
2009-02-11 |
2010-08-19 |
Lyka Labs Limited |
Liposomal citicoline injection
|
|
CN104922699B
(zh)
|
2009-03-12 |
2020-07-24 |
阿尔尼拉姆医药品有限公司 |
脂质配制的组合物以及用于抑制Eg5和VEGF基因表达的方法
|
|
JP5487666B2
(ja)
*
|
2009-03-23 |
2014-05-07 |
コニカミノルタ株式会社 |
内水相を固定化することを特徴とするリポソームの製造方法
|
|
EP2416652B1
(en)
|
2009-05-05 |
2018-11-07 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
|
KR20220150411A
(ko)
|
2009-05-05 |
2022-11-10 |
알닐람 파마슈티칼스 인코포레이티드 |
지질 조성물
|
|
SI3431076T1
(sl)
|
2009-06-10 |
2022-04-29 |
Arbutus Biopharma Corporation |
Izboljšana lipidna formulacija
|
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
|
FR2948035B1
(fr)
*
|
2009-07-20 |
2015-04-24 |
Centre Nat Rech Scient |
Procede de fabrication de capsules, capsules ainsi obtenues et utilisation desdites capsules
|
|
EP2810643A3
(en)
|
2009-08-14 |
2015-03-11 |
Alnylam Pharmaceuticals Inc. |
Lipid formulated compositions and mehods for inhibiting expression of a gene from the ebola virus
|
|
WO2011038160A2
(en)
|
2009-09-23 |
2011-03-31 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
|
WO2011056682A1
(en)
|
2009-10-27 |
2011-05-12 |
The University Of British Columbia |
Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
|
|
EP3296398A1
(en)
|
2009-12-07 |
2018-03-21 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
AU2010330814B2
(en)
|
2009-12-18 |
2017-01-12 |
Acuitas Therapeutics Inc. |
Methods and compositions for delivery of nucleic acids
|
|
CA2799091A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
SG186085A1
(en)
|
2010-06-03 |
2013-01-30 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the delivery of active agents
|
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
EP3266881B1
(en)
|
2010-11-05 |
2019-12-25 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
|
AU2011326732B2
(en)
|
2010-11-09 |
2016-07-21 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use thereof
|
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
ES2634669T3
(es)
|
2011-02-08 |
2017-09-28 |
Halozyme, Inc. |
Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata
|
|
DK2729127T3
(en)
|
2011-07-04 |
2018-08-06 |
Statens Seruminstitut |
METHODS FOR LIPOSOMES PREPARATION
|
|
US9701623B2
(en)
|
2011-09-27 |
2017-07-11 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
|
US20150240238A1
(en)
|
2011-11-17 |
2015-08-27 |
The Regents Of The University Of California |
Therapeutic rna switches compositions and methods of use
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
EP2606897A1
(en)
|
2011-12-22 |
2013-06-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and compositions for the treatment of diseases caused by enveloped viruses
|
|
DK2817287T3
(da)
|
2012-02-24 |
2019-01-02 |
Arbutus Biopharma Corp |
Trialkyl kationisk lipid og metoder til anvendelse deraf
|
|
WO2013138251A1
(en)
|
2012-03-12 |
2013-09-19 |
The Board Of Trustes Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
|
EP2666456A1
(en)
|
2012-05-21 |
2013-11-27 |
Natura Bisse International, S.A. |
Cometic compositions comprising magnetosomes and uses thereof
|
|
CN105025904A
(zh)
|
2012-09-04 |
2015-11-04 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
KR101465365B1
(ko)
*
|
2013-10-15 |
2014-11-25 |
성균관대학교산학협력단 |
리포좀 내 고분자 충진된 다중 기능 복합 입자체 및 이의 제조방법
|
|
KR101638156B1
(ko)
|
2013-10-29 |
2016-07-08 |
가톨릭대학교 산학협력단 |
C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
|
|
PL3186281T3
(pl)
|
2014-08-28 |
2019-10-31 |
Halozyme Inc |
Terapia skojarzona enzymem rozkładającym hialuronian i inhibitorem punktu kontrolnego odpowiedzi immunologicznej
|
|
KR20170075742A
(ko)
|
2014-10-02 |
2017-07-03 |
프로티바 바이오쎄라퓨틱스, 인코포레이티드 |
B형 간염 바이러스 유전자 발현을 제거하는 조성물 및 방법
|
|
AU2015364508A1
(en)
|
2014-12-18 |
2017-07-06 |
Alnylam Pharmaceuticals, Inc. |
ReversirTM compounds
|
|
JP6316182B2
(ja)
*
|
2014-12-19 |
2018-04-25 |
富士フイルム株式会社 |
リポソームの製造方法及びリポソーム製造装置
|
|
EA201791437A1
(ru)
|
2014-12-31 |
2017-12-29 |
Лантеус Медикал Имэджинг, Инк. |
Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы
|
|
US9931298B2
(en)
|
2015-05-26 |
2018-04-03 |
Comfort Care For Animals Llc |
Liposome loading
|
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
|
CN108350455A
(zh)
|
2015-07-29 |
2018-07-31 |
阿布特斯生物制药公司 |
用于使b型肝炎病毒基因表达沉默的组合物和方法
|
|
US10429302B2
(en)
|
2015-08-11 |
2019-10-01 |
Scintillon Institute For Biomedical And Bioenergy Research |
Optical analyses of particles and vesicles
|
|
CN108136023B
(zh)
|
2015-08-12 |
2021-07-27 |
北卡罗莱纳州立大学 |
血小板膜包覆的药物递送系统
|
|
KR102408525B1
(ko)
|
2016-01-08 |
2022-06-13 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
화물 전달용 지질 2중층 코팅물을 가진 메조다공성 실리카 나노입자
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
KR20230088514A
(ko)
|
2016-04-14 |
2023-06-19 |
프레드 허친슨 캔서 센터 |
표적화 핵산 나노수송체를 이용하여 치료 세포를 프로그램화하기 위한 조성물 및 방법
|
|
TWI832081B
(zh)
|
2016-05-04 |
2024-02-11 |
美商藍瑟斯醫學影像公司 |
用於形成充氣微球體及成像個體之方法、震盪裝置及電腦可讀軟體
|
|
WO2018006052A1
(en)
|
2016-06-30 |
2018-01-04 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
|
CA3049244A1
(en)
|
2017-01-05 |
2018-07-12 |
Fred Hutchinson Cancer Research Center |
Systems and methods to improve vaccine efficacy
|
|
WO2019118806A1
(en)
|
2017-12-14 |
2019-06-20 |
Solid Biosciences Inc. |
Non-viral production and delivery of genes
|
|
US20220305108A1
(en)
|
2019-06-20 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
|
US20210023023A1
(en)
*
|
2019-07-25 |
2021-01-28 |
Vasayo, Llc |
Liposomal nutraceutical compositions and methods of making the same
|
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
EP4312536A1
(en)
|
2021-04-01 |
2024-02-07 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
|
WO2023018990A2
(en)
|
2021-08-12 |
2023-02-16 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
|
WO2023144792A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
|
NL2035417A
(en)
|
2022-07-19 |
2024-01-26 |
Coty Inc |
Cosmetic composition
|
|
WO2024031051A1
(en)
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
